Equity funds, which had delivered robust returns in the past few years, are facing turbulence amid the latest rout in the market.
The data from Value Research reveals that of a total of 513 equity schemes, around 372 have given negative returns in the past year.
There are around 14 schemes which have fallen more than 20 per cent in the past year, largely in the international category of funds.
Apart from international funds, the stragglers include funds from small-cap, equity-linked saving schemes, and pharmaceutical (pharma) categories.
On average, international funds have given negative returns of 17 per cent in the past year. Pharma